Join this live webinar to learn more.
Viral vector manufacturing continues to face challenges in delivering consistent quality and achieving high productivity at scale. This webinar will highlight how CDMO innovation drives improvements across upstream and downstream processes and accelerates analytical development for lentiviral and adeno-associated virus (AAV) vectors. Discussion will cover strategies to enhance productivity, quality and yield, while addressing key bottlenecks in vector manufacturing. Participants will gain insights into the evolving approaches that are enabling more robust, flexible, and efficient viral vector manufacturing to support next-generation gene therapies. In this webinar, you’ll learn more about:
- Cutting-edge innovation technologies improving vector purity and productivity
- A CDMO platform approach ensuring seamless integration of technologies and processes to drive performance
- A rapid development of vector genome titre and gene expression assays within just 2 months
Offered Free by: OXB
See All Resources from: OXB
